46 results on '"Neleman T"'
Search Results
2. Predictors of successful post-PCI optimization in vessels with post-PCI fractional flow reserve <0.90: findings from the FFR REACT trial
- Author
-
Neleman, T, primary, Ziedses Des Plantes, A C, additional, Scoccia, A, additional, Groenland, F T W, additional, Van Zandvoort, L J C, additional, Ligthart, J M R, additional, Witberg, K T, additional, Boersma, H, additional, Nuis, R J, additional, Den Dekker, W K, additional, Diletti, R, additional, Wilschut, J, additional, Van Mieghem, N M, additional, and Daemen, J, additional more...
- Published
- 2023
- Full Text
- View/download PDF
Catalog
3. Diagnostic accuracy of angiography-based vessel fractional flow reserve after chronic coronary total occlusion recanalization
- Author
-
Scoccia, A, primary, Scarparo, P, additional, Neleman, T, additional, Wilschut, J, additional, Den Dekker, W, additional, Zijlstra, F, additional, Van Mieghem, N, additional, Daemen, J, additional, and Diletti, R, additional more...
- Published
- 2022
- Full Text
- View/download PDF
4. The Prognostic Value of a Validated and Automated Intravascular Ultrasound-Derived Calcium Score
- Author
-
Neleman, T. (Tara), Liu, S. (Shengnan), Tovar Forero, M.N. (Maria N.), Hartman, E.M.J. (Eline), Ligthart, J.M.R. (Jürgen), Witberg, K.Th. (Karen), Cummins, P.A. (Paul), Zijlstra, F. (Felix), Mieghem, N.M. (Nicolas) van, Boersma, H. (Eric), Soest, G. (Gijs) van, Daemen, J. (Joost), Neleman, T. (Tara), Liu, S. (Shengnan), Tovar Forero, M.N. (Maria N.), Hartman, E.M.J. (Eline), Ligthart, J.M.R. (Jürgen), Witberg, K.Th. (Karen), Cummins, P.A. (Paul), Zijlstra, F. (Felix), Mieghem, N.M. (Nicolas) van, Boersma, H. (Eric), Soest, G. (Gijs) van, and Daemen, J. (Joost) more...
- Abstract
Background: Coronary calcification has been linked to cardiovascular events. We developed and validated an algorithm to automatically quantify coronary calcifications on intravascular ultrasound (IVUS). We aimed to assess the prognostic value of an IVUS-calcium score (ICS) on patient-oriented composite endpoint (POCE). Methods: We included patients that underwent coronary angiography plus pre-procedural IVUS imaging. The ICS was calculated per patient. The primary endpoint was a composite of all-cause mortality, stroke, myocardial infarction, and revascularization (POCE). Results: In a cohort of 408 patients, median ICS was 85. Both an ICS ≥ 85 and a 100 unit increase in ICS increased the risk of POCE at 6-year follow-up (adjusted hazard ratio (aHR) 1.51, 95%CI 1.05–2.17, p value = 0.026, and aHR 1.21, 95%CI 1.04–1.41, p value = 0.014, respectively). Conclusions: The ICS, calculated by a validated automated algorithm derived from routine IVUS pullbacks, was strongly associated with the long-term risk of POCE. Graphical abstract: [Figure not available: see fulltext.]. more...
- Published
- 2021
- Full Text
- View/download PDF
5. AUTOMATED QUANTITATIVE ASSESSMENT OF CORONARY CALCIFICATION USING INTRAVASCULAR ULTRASOUND
- Author
-
Liu, SN, Neleman, T., Hartman, E.M.J., Ligthart, J.M.R. (Jürgen), Witberg, K.Th. (Karen), Steen, A.F.W. (Ton) van der, Wentzel, J.J. (Jolanda), Daemen, J. (Joost), Soest, G. (Gijs) van, Liu, SN, Neleman, T., Hartman, E.M.J., Ligthart, J.M.R. (Jürgen), Witberg, K.Th. (Karen), Steen, A.F.W. (Ton) van der, Wentzel, J.J. (Jolanda), Daemen, J. (Joost), and Soest, G. (Gijs) van more...
- Abstract
Coronary calcification represents a challenge in the treatment of coronary artery disease by stent placement. It negatively affects stent expansion and has been related to future adverse cardiac events. Intravascular ultrasound (IVUS) is known for its high sensitivity in detecting coronary calcification. At present, automated quantification of calcium as detected by IVUS is not available. For this reason, we developed and validated an optimized framework for accurate automated detection and quantification of calcified plaque in coronary atherosclerosis as seen by IVUS. Calcified lesions were detected by training a supported vector classifier per IVUS A-line on manually annotated IVUS images, followed by post-processing using regional information. We applied our framework to 35 IVUS pullbacks from each of the three commonly used IVUS systems. Cross-validation accuracy for each system was >0.9, and the testing accuracy was 0.87, 0.89 and 0.89 for the three systems. Using the detection result, we propose an IVUS calcium score, based on the fraction of calcium-positive A-lines in a pullback segment, to quantify the extent of calcified plaque. The high accuracy of the proposed classifier suggests that it may provide a robust and accurate tool to assess the presence and amount of coronary calcification and, thus, may play a role in imageguided coronary interventions. (E-mail: g.vansoest@erasmusmc.nl) more...
- Published
- 2020
- Full Text
- View/download PDF
6. Correlation between 3D-QCA based FFR and quantitative lumen assessment by IVUS for left main coronary artery stenoses
- Author
-
Tomaniak, M. (Mariusz), Masdjedi, K. (Kaneshka), Zandvoort, L.J.C. (Laurens) van, Neleman, T. (Tara), Tovar Forero, M.N. (Maria N), Vermaire, A. (Alise), Kochman, W. (Waclav), Kardys, I. (Isabella), Dekker, W.K. (Wijnand) den, Wilschut, J. (Jeroen), Diletti, R. (Roberto), Jaegere, P.P.T. (Peter) de, Mieghem, N.M. (Nicolas) van, Zijlstra, F. (Felix), Daemen, J. (Joost), Tomaniak, M. (Mariusz), Masdjedi, K. (Kaneshka), Zandvoort, L.J.C. (Laurens) van, Neleman, T. (Tara), Tovar Forero, M.N. (Maria N), Vermaire, A. (Alise), Kochman, W. (Waclav), Kardys, I. (Isabella), Dekker, W.K. (Wijnand) den, Wilschut, J. (Jeroen), Diletti, R. (Roberto), Jaegere, P.P.T. (Peter) de, Mieghem, N.M. (Nicolas) van, Zijlstra, F. (Felix), and Daemen, J. (Joost) more...
- Abstract
Objectives: We aimed to evaluate the feasibility of using three dimensional-quantitative coronary angiography (3D-QCA) based fractional flow reserve (FFR) (vessel fractional flow reserve [vFFR], CAAS8.1, Pie Medical Imaging) and to correlate vFFR values with intravascular ultrasound (IVUS) for the evaluation of intermediate left main coronary artery (LMCA) stenosis. Background: 3D-QCA derived FFR indices have been recently developed for less invasive functional lesion assessment. However, LMCA lesions were vastly under-represented in first validation studies. Methods: This observational single-center cohort study enrolled consecutive patients with stable angina, unstable angina, or non-ST-segment elevation myocardial infarction and nonostial, intermediate grade LMCA stenoses who underwent IVUS evaluation. vFFR was computed based on two angiograms with optimal LMCA stenosis projection and correlated with IVUS-derived minimal lumen area (MLA). Results: A total of 256 patients with intermediate grade LMCA stenosis evaluated with IVUS were screened for eligibility; 147 patients met the clinical inclusion criteria and had a complete IVUS LMCA footage available, of them, 63 patients (63 lesions) underwent 3D-QCA and vFFR analyses. The main reason for screening failure was insufficient quality of the angiogram (51 patients,60.7%). Mean age was 65 ± 11 years, 75% were male. Overall, mean MLA within LMCA was 8.77 ± 3.17 mm2, while mean vFFR was 0.87 ± 0.09. A correlation was observed between vFFR and LMCA MLA (r =.792, p =.001). The diagnostic accuracy of vFFR ≤0.8 in identifying lesions with MLA < 6.0 mm2 (sensitivity 98%, specificity 71.4%, area under the curve (AUC) 0.95, 95% confidence interval (CI) 0.89–1.00, p =.001) was good. Conclusions: In patients with good quality angiographic visualizat more...
- Published
- 2020
- Full Text
- View/download PDF
7. Intracoronary polarimetry for characterizing coronary plaque vulnerability in patients with coronary artery disease
- Author
-
Otsuka, K, primary, Villiger, M, additional, Van Zandvoort, L.J.C, additional, Neleman, T, additional, Karanasos, A, additional, Dijikstra, J, additional, Van Soest, G, additional, Regar, E, additional, Nadkarni, S.K, additional, Daemen, J, additional, and Bouma, B.E, additional more...
- Published
- 2020
- Full Text
- View/download PDF
8. Polarization-sensitive OFDI findings of vascular tissue response following drug-eluting stent implantation in patients with coronary artery disease
- Author
-
Otsuka, K, primary, Villiger, M, additional, Van Zandvoort, L.J.C, additional, Neleman, T, additional, Karanasos, A, additional, Dijkstra, J, additional, Nadkarni, S.K, additional, Regar, E, additional, Daemen, J, additional, and Bouma, B.E, additional more...
- Published
- 2020
- Full Text
- View/download PDF
9. Post percutaneous coronary intervention physiology in patients presenting with ST-segment elevation myocardial infarction.
- Author
-
Groenland FTW, Ziedses des Plantes AC, Scoccia A, Neleman T, Masdjedi K, Kardys I, Diletti R, Van Mieghem NM, and Daemen J
- Abstract
Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Joost Daemen received institutional grant/research support from Abbott Vascular, ACIST Medical, Boston Scientific, Medtronic, Microport, Pie Medical, and ReCor Medical, and consultancy and speaker fees from Abbott, Abiomed, ACIST medical, Boston Scientific, CardiacBooster, Cardialysis BV, Kaminari Medical, Medtronic, ReCor Medical, Pie Medical, PulseCath, and Siemens Health Care. Nicolas van Mieghem received institutional research grant support from Abbott Vascular, Biotronik, Boston Scientific, Daiichi Sankyo, Edwards Lifesciences, and Medtronic, and consultancy fees from Abbott, Abiomed, Amgen, Anteris, Boston Scientific, Daiichi Sankyo, JenaValve, Medtronic, PulseCath BV, and Teleflex. Tara Neleman has received institutional grant support from ACIST Medical Systems. The remaining authors report no relationships that could be construed as a conflict of interest. more...
- Published
- 2023
- Full Text
- View/download PDF
10. Clinical and Vessel Characteristics Associated With Hard Outcomes After PCI and Their Combined Prognostic Implications.
- Author
-
Yang S, Hwang D, Zhang J, Park J, Yun JP, Lee JM, Nam CW, Shin ES, Doh JH, Chen SL, Kakuta T, Toth GG, Piroth Z, Johnson NP, Hakeem A, Uretsky BF, Hokama Y, Tanaka N, Lim HS, Ito T, Matsuo A, Azzalini L, Leesar MA, Neleman T, van Mieghem NM, Diletti R, Daemen J, Collison D, Collet C, De Bruyne B, and Koo BK more...
- Subjects
- Humans, Middle Aged, Aged, Prognosis, Stroke Volume, Ventricular Function, Left, Drug-Eluting Stents, Fractional Flow Reserve, Myocardial, Percutaneous Coronary Intervention adverse effects, Myocardial Infarction
- Abstract
Background Cardiac death or myocardial infarction still occurs in patients undergoing contemporary percutaneous coronary intervention (PCI). We aimed to identify adverse clinical and vessel characteristics related to hard outcomes after PCI and to investigate their individual and combined prognostic implications. Methods and Results From an individual patient data meta-analysis of 17 cohorts of patients who underwent post-PCI fractional flow reserve measurement after drug-eluting stent implantation, 2081 patients with available clinical and vessel characteristics were analyzed. The primary outcome was cardiac death or target-vessel myocardial infarction at 2 years. The mean age of patients was 64.2±10.2 years, and the mean angiographic percent diameter stenosis was 63.9%±14.3%. Among 11 clinical and 8 vessel features, 4 adverse clinical characteristics (age ≥65 years, diabetes, chronic kidney disease, and left ventricular ejection fraction <50%) and 2 adverse vessel characteristics (post-PCI fractional flow reserve ≤0.80 and total stent length ≥54 mm) were identified to independently predict the primary outcome (all P <0.05). The number of adverse vessel characteristics had additive predictability for the primary end point to that of adverse clinical characteristics (area under the curve 0.72 versus 0.78; P =0.03) and vice versa (area under the curve 0.68 versus 0.78; P =0.03). The cumulative event rate increased in the order of none, either, and both of adverse clinical characteristics ≥2 and adverse vessel characteristics ≥1 (0.3%, 2.4%, and 5.3%; P for trend <0.01). Conclusions In patients undergoing drug-eluting stent implantation, adverse clinical and vessel characteristics were associated with the risk of cardiac death or target-vessel myocardial infarction. Because these characteristics showed independent and additive prognostic value, their integrative assessment can optimize post-PCI risk stratification. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT04684043. www.crd.york.ac.uk/prospero/. Unique Identifier: CRD42021234748. more...
- Published
- 2023
- Full Text
- View/download PDF
11. Long-term clinical outcomes in patients with non-ST-segment Elevation Acute Coronary Syndrome and ST-segment elevation myocardial infarction with thrombolysis in myocardial infarction 0 flow.
- Author
-
Aarts BRA, Groenland FTW, Elscot J, Neleman T, Wilschut JM, Kardys I, Nuis RJ, Diletti R, Daemen J, Van Mieghem NM, and den Dekker WK
- Abstract
Background: Thrombolysis in Myocardial Infarction (TIMI) 0 flow often characterizes ST-segment Elevation Myocardial Infarction (STEMI) patients, but may also feature in non-ST-segment Elevation Acute Coronary Syndrome (NSTE-ACS). Since recanalization usually occurs later in NSTE-ACS patients, the aim of this study was to assess whether patients presenting with NSTE-ACS and TIMI 0 flow have worse clinical outcomes as compared to patients presenting with STEMI and TIMI 0 flow., Methods: A single-center retrospective cohort study was conducted with patients treated for NSTE-ACS and STEMI with TIMI 0 flow at diagnostic angiogram between January 2015 and December 2019. The two patient groups were 1:1 matched using a propensity score logistic regression model. The primary outcome was Major Adverse Cardiac Events (MACE), a composite of all-cause mortality, any myocardial infarction, coronary artery bypass graft, urgent target vessel revascularization or stroke during long term follow-up., Results: The total population consisted of 1255 ACS patients, of which 249 NSTE-ACS and 1006 STEMI patients. After propensity score matching, 234 NSTE-ACS patients were matched with 234 STEMI patients. In this matched population, the mean age was 62.6 (±12.4) years and 75.2 % of the patients was male. The median follow-up time was 3.2 years. MACE rates during follow-up were similar between the two matched groups (HR = 0.84 [95 % CI 0.60 - 1.12] with p = 0.33) with cumulative event-free survival of 63.3 % in the NSTE-ACS group vs 59.3 % in the STEMI group at 6 year follow-up., Conclusion: In this retrospective study, a culprit lesion with TIMI 0 flow has similar clinical outcome in NSTE-ACS and STEMI patients. Further research is warranted to determine optimal the timing of PCI in NSTE-ACS patients with TIMI 0 flow., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 The Author(s).) more...
- Published
- 2023
- Full Text
- View/download PDF
12. Culprit lesion plaque characterization and thrombus grading by high-definition intravascular ultrasound in patients with ST-segment elevation myocardial infarction.
- Author
-
Groenland FTW, Ziedses des Plantes AC, Neleman T, Scoccia A, Ligthart JMR, Witberg KT, Mahmoud KD, Nuis RJ, den Dekker WK, Wilschut JM, Diletti R, Zijlstra F, Van Mieghem NM, and Daemen J
- Subjects
- Humans, Male, Middle Aged, Female, Prospective Studies, Coronary Angiography, Treatment Outcome, Ultrasonography, Interventional methods, ST Elevation Myocardial Infarction diagnostic imaging, ST Elevation Myocardial Infarction therapy, Percutaneous Coronary Intervention adverse effects, Myocardial Infarction pathology, Plaque, Atherosclerotic, Thrombosis
- Abstract
Background: Dedicated prospective studies investigating high-definition intravascular ultrasound (HD-IVUS)-guided primary percutaneous coronary intervention (PCI) are lacking. The aim of this study was to qualify and quantify culprit lesion plaque characteristics and thrombus using HD-IVUS in patients presenting with ST-segment elevation myocardial infarction (STEMI)., Methods: The SPECTRUM study is a prospective, single-center, observational cohort study investigating the impact of HD-IVUS-guided primary PCI in 200 STEMI patients (NCT05007535). The first 100 study patients with a de novo culprit lesion and a per-protocol mandated preintervention pullback directly after vessel wiring were subject to a predefined imaging analysis. Culprit lesion plaque characteristics and different thrombus types were assessed. An IVUS-derived thrombus score, including a 1-point adjudication for a long total thrombus length, long occlusive thrombus length, and large maximum thrombus angle, was developed to differentiate between low (0-1 points) and high (2-3 points) thrombus burden. Optimal cut-off values were obtained using receiver operating characteristic curves., Results: The mean age was 63.5 (±12.1) years and 69 (69.0%) patients were male. The median culprit lesion length was 33.5 (22.8-38.9) mm. Plaque rupture and convex calcium were appreciated in 48 (48.0%) and 10 (10.0%) patients, respectively. Thrombus was observed in 91 (91.0%) patients (acute thrombus 3.3%; subacute thrombus 100.0%; organized thrombus 22.0%). High IVUS-derived thrombus burden was present in 37/91 (40.7%) patients and was associated with higher rates of impaired final thrombolysis in myocardial infarction flow (grade 0-2) (27.0% vs. 1.9%, p < 0.001)., Conclusions: HD-IVUS in patients presenting with STEMI allows detailed culprit lesion plaque characterization and thrombus grading that may guide tailored PCI., (© 2023 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC.) more...
- Published
- 2023
- Full Text
- View/download PDF
13. Validation of Segmental Post-PCI Physiological Gradients With IVUS-Detected Focal Lesions and Stent Underexpansion.
- Author
-
Neleman T, Scoccia A, Groenland FTW, Ziedses des Plantes AC, van Zandvoort LJC, Ligthart JMR, Witberg KT, Lenzen MJ, Boersma E, Nuis RJ, den Dekker WK, Diletti R, Wilschut J, Zijlstra F, Van Mieghem NM, and Daemen J more...
- Subjects
- Humans, Coronary Angiography, Treatment Outcome, Ultrasonography, Interventional, Stents, Coronary Vessels diagnostic imaging, Predictive Value of Tests, Percutaneous Coronary Intervention adverse effects, Fractional Flow Reserve, Myocardial, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease therapy
- Abstract
Background: Segmental postpercutaneous coronary intervention (PCI) pressure gradients may detect residual disease and potential targets for optimization. However, universal definitions of relevant segmental gradients are lacking., Objectives: This study sought to evaluate the diagnostic performance of post-PCI fractional flow reserve (FFR), distal coronary pressure-to-aortic pressure ratio (Pd/Pa), and diastolic pressure ratio (dPR) gradients to detect residual focal lesions and stent underexpansion as observed by intravascular ultrasound (IVUS)., Methods: Patients from the IVUS-guided optimization arm of the FFR REACT (FFR-guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care) trial with complete IVUS and FFR pullback data were included. Patients with angiographically successful PCI and post-PCI FFR <0.90 underwent FFR, Pd/Pa, and IVUS pullbacks. dPR was calculated offline using dedicated software. Segmental pressure gradients (distal, in stent, and proximal) in segments ≥5 mm were evaluated against IVUS-detected residual disease (distal or proximal focal lesions and stent underexpansion)., Results: A total of 139 vessels were included (mean post-PCI FFR: 0.83 ± 0.05, range 0.56-0.89). Focal distal and proximal lesions were detected by IVUS in 23 (17.4%) of 132 and 14 (12.6%) of 111 vessels, respectively, whereas stent underexpansion was present in 86 (61.9%) vessels. Diagnostic ability of segmental FFR gradients to predict IVUS-detected distal and proximal lesions was moderate-to-good (area under the curve [AUC]: 0.69 and 0.84, respectively) and poor to moderate for segmental Pd/Pa and dPR gradients (AUC ranging from 0.58 to 0.69). In-stent gradients had no discriminative ability to detect stent underexpansion (FFR AUC: 0.52; Pd/Pa AUC: 0.54; dPR AUC: 0.55)., Conclusions: In patients with post-PCI FFR <0.90, segmental post-PCI pressure gradients have moderate discriminative ability to identify IVUS-detected focal lesions but no discriminative ability to identify IVUS-detected stent underexpansion., Competing Interests: Funding Support and Author Disclosures The Erasmus Medical Center received institutional research support from ACIST Medical Systems, Inc. Ms Neleman and Dr Diletti have received institutional grant support from ACIST Medical Systems. Dr Van Mieghem has received institutional research grant support from Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Daiichi Sankyo, PulseCath BV, and Abiomed. Dr Daemen has received institutional grant/research support from Abbott Vascular, Boston Scientific, ACIST Medical Systems, Medtronic, Pie Medical, and ReCor medical; and received consulting and lecture fees from Abbott Vascular, Abiomed, ACIST Medical Systems, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2023. Published by Elsevier Inc.) more...
- Published
- 2023
- Full Text
- View/download PDF
14. Optical coherence tomography-derived predictors of stent expansion in calcified lesions.
- Author
-
Ziedses des Plantes AC, Scoccia A, Neleman T, Groenland FTW, van Zandvoort LJC, Ligthart JMR, Witberg KT, Liu S, Boersma E, Nuis RJ, den Dekker WK, Wilschut J, Diletti R, Zijlstra F, Van Mieghem NM, and Daemen J more...
- Subjects
- Humans, Tomography, Optical Coherence methods, Retrospective Studies, Calcium, Treatment Outcome, Coronary Vessels diagnostic imaging, Coronary Vessels pathology, Predictive Value of Tests, Stents, Coronary Angiography methods, Percutaneous Coronary Intervention adverse effects, Vascular Calcification diagnostic imaging, Vascular Calcification therapy, Vascular Calcification pathology, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease therapy, Coronary Artery Disease pathology
- Abstract
Background: Severe coronary artery calcification is associated with stent underexpansion and subsequent stent failure., Aims: We aimed to identify optical coherence tomography (OCT)-derived predictors of absolute (minimal stent area [MSA]) and relative stent expansion in calcified lesions., Methods: This retrospective cohort study included patients who underwent percutaneous coronary intervention (PCI) with OCT assessment before and after stent implantation between May 2008 and April 2022. Pre-PCI OCT was used to assess calcium burden and post-PCI OCT was used to assess absolute and relative stent expansion., Results: A total of 361 lesions in 336 patients were analyzed. Target lesion calcification (defined as OCT-detected maximum calcium angle ≥ 30°) was present in 242 (67.0%) lesions. Following PCI, median MSA was 5.37 mm
2 in calcified lesions and 6.24 mm2 in noncalcified lesions (p < 0.001). Median stent expansion was 78% in calcified lesions and 83% in noncalcified lesions (p = 0.325). In the subset of calcified lesions, average stent diameter, preprocedural minimal lumen area, and total calcium length were independent predictors of MSA in multivariable analysis (mean difference 2.69 mm2 /mm2 , 0.52 mm2 /mm, and -0.28 mm2 /5 mm, respectively, all p < 0.001). Total stent length was the only independent predictor of relative stent expansion (mean difference -0.465% per mm, p < 0.001). Calcium angle, thickness, and the presence of nodular calcification were not significantly associated with MSA or stent expansion in multivariable analyses., Conclusion: Calcium length appeared to be the most important OCT-derived predictor of MSA, whereas stent expansion was mainly determined by total stent length., (© 2023 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC.) more...- Published
- 2023
- Full Text
- View/download PDF
15. Predictors of discordance between fractional flow reserve (FFR) and diastolic pressure ratio (dPR) in intermediate coronary lesions.
- Author
-
Scoccia A, Neleman T, Ziedses des Plantes AC, Groenland FTW, M R Ligthart J, den Dekker WK, Diletti R, Wilschut J, Jan Nuis R, Zijlstra F, Boersma E, Van Mieghem NM, and Daemen J
- Abstract
Background: Recently, non-hyperemic pressure ratios (NHPRs) have been validated as a reliable alternative to fractional flow reserve (FFR). However, a discordance between FFR and NHPRs is observed in 20-25% of cases. The aim of this study is to evaluate predictors of discordance between FFR and diastolic Pressure ratio (dPR)., Methods: PREDICT is a retrospective, single center, investigator-initiated study including 813 patients (1092vessels) who underwent FFR assessment of intermediate coronary lesions (angiographic 30%-80% stenosis). dPR was calculated using individual pressure waveforms and dedicated software. Clinical, angiographic and hemodynamic variables were compared between patients with concordant and discordant FFR and dPR values., Results: Median age was 65 (IQR:59-73) years and 70% were male. Hemodynamically significant lesions, as defined by FFR ≤ 0.80, and dPR ≤ 0.89, were identified in 29.6% and 30.3% of cases, respectively. Overall, FFR and dPR values were discordant in 22.1% patients (17.4% of the vessels). Discordance was related to FFR+/dPR- and FFR-/dPR + in 11.8% and 10.3% of patients, respectively.In case of FFR-dPR discordance, a higher prevalence of left anterior descending arteries lesions was observed (70.5% vs. 53.1%, p < 0.001) and mean values of both FFR and dPR were significantly lower (FFR 0.81 ± 0.05 vs 0.85 ± 0.08, p < 0.001, and dPR 0.89 ± 0.04 vs 0.92 ± 0.08,p < 0.001) as compared to vessels with FFR and dPR concordance. Following multivariable adjustment, dPR delta (defined as the absolute difference between measured dPR to the cut-off value of 0.89) turned out to be the only independent predictor of discordance (OR = 0.74, 95% CI 0.68-0.79, p < 0.001)., Conclusion: Our study suggests that FFR-to-dPR discordance occurs in approximately one-fifth of patients. Absolute dPR delta appears to be the only independent predictor of discordance., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper: [Conflicts of interest: Joost Daemen received institutional grant/research support from Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Microport, Pie Medical, and ReCor medical, and consultancy and speaker fees from Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic. Nicolas M. van Mieghem received research grant support from Abbott Vascular, Boston scientific, Biotronik, Edwards Lifesciences, Medtronic, Abiomed, PulseCath BV, Daiichi Sankyo. The other authors have no conflict of interest to declare.]., (© 2023 The Authors. Published by Elsevier B.V.) more...
- Published
- 2023
- Full Text
- View/download PDF
16. Changes in post-PCI optimisation strategies with post-procedural FFR followed by IVUS.
- Author
-
Neleman T, Groenland FTW, Ziedses des Plantes AC, Scoccia A, van Zandvoort LJC, Boersma E, Nuis RJ, den Dekker WK, Diletti R, Wilschut J, Zijlstra F, Van Mieghem NM, and Daemen J
- Subjects
- Humans, Coronary Angiography, Treatment Outcome, Percutaneous Coronary Intervention, Fractional Flow Reserve, Myocardial, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease surgery
- Published
- 2023
- Full Text
- View/download PDF
17. Initial experience with orbital atherectomy in a tertiary centre in the Netherlands.
- Author
-
den Dekker WK, Siskos AA, Wilschut JM, Nuis RJ, Scarparo P, Neleman T, Masdjedi K, Ligthart JMR, Diletti R, Daemen J, and Van Mieghem NM
- Abstract
Background: In January 2021, the Diamondback 360 orbital atherectomy (OA) system received CE mark approval and became available in Europe. The first procedure in Europe was performed at the Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands., Aims: To report the procedural safety and efficacy of the initial experience with OA in a tertiary care institution in the Netherlands., Methods: Patients with de novo severely calcified coronary artery disease who were treated with intended invasive imaging-guided OA were included in a prospective single-centre registry. Device success, defined as less than 50% stenosis after OA, and procedural success, defined as successful stent implantation with less than 50% residual stenosis, were evaluated. Calcium debulking effects were assessed by invasive imaging. Safety was assessed up to 30 days after the index procedure., Results: Between February 2021 and June 2021, 29 patients with a total of 39 coronary arteries underwent OA. Target lesions were heavily calcified with a mean length of 32 mm and a calcium arc of 320 degrees. Invasive imaging was applied in all but one patient and 36 vessels. Superficial sanding was observed in almost all vessels (90%) and fracturing of deeper medial calcium in more than half of the vessels (63%), with a device success of 66% and procedural success of 94%. The mean stent symmetry index was 0.84, indicating good circular stent expansion. No primary safety events occurred during 30 days of follow-up., Conclusion: Our initial experience with OA for heavily calcified coronary lesions demonstrated favourable debulking effects and plaque modification, with high procedural success and clinical safety., (© 2022. The Author(s).) more...
- Published
- 2023
- Full Text
- View/download PDF
18. Coronary lithotripsy - a state of the art review.
- Author
-
Neleman T, Ziedses des Plantes AC, and Daemen J
- Subjects
- Humans, Treatment Outcome, Coronary Angiography, Vascular Calcification diagnostic imaging, Vascular Calcification therapy, Percutaneous Coronary Intervention, Lithotripsy adverse effects, Coronary Artery Disease therapy
- Abstract
Lesion calcification is frequently encountered during percutaneous coronary intervention and has been directly linked to procedural complications and future cardiac events. Intravascular lithotripsy is a novel balloon-based modality that does not rely on barotrauma or debulking, but converts electrical energy into mechanical energy creating sonic pressure waves that selectively disrupt calcium. The present review provides an overview of its mechanism of action, the available evidence on its safety and efficacy and indications for use., Competing Interests: Declaration of Competing Interest Joost Daemen received institutional grant/research support from Astra Zeneca, Abbott Vascular, Boston Scientific, ACIST Medical Systems, Medtronic, Pie Medical, and ReCor Medical. The remaining authors have nothing to disclose., (Copyright © 2022. Published by Elsevier Inc.) more...
- Published
- 2023
- Full Text
- View/download PDF
19. Acute-setting vs. staged-setting vessel fractional flow reserve of intermediate non-culprit lesions in patients with ST-segment elevation myocardial infarction (FAST STAGED study).
- Author
-
Huang J, Groenland FTW, Scoccia A, Ziedses des Plantes AC, Neleman T, Van Mieghem NM, and Daemen J
- Abstract
Competing Interests: Nicolas Van Mieghem received institutional research grant support from Abbott Vascular, Abiomed, Boston Scientific, Daiichi-Sankyo, Edward Lifesciences, Medtronic, and PulseCath. Joost Daemen received institutional grant/research support from Abbott Vascular, ACIST Medical, Astra Zeneca, Boston Scientific, Medtronic, Microport, Pie Medical, and ReCor Medical, and consultancy and speaker fees from Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, CardiacBooster, Cardialysis BV, Kaminari Medical, Medtronic, Pie Medical, PulseCath, ReCor Medical, Sanofi, and Siemens Health Care. The remaining authors report no relationships that could be construed as a conflict of interest. more...
- Published
- 2023
- Full Text
- View/download PDF
20. Vessel fractional flow reserve-based non-culprit lesion reclassification in patients with ST-segment elevation myocardial infarction: Impact on treatment strategy and clinical outcome (FAST STEMI I study).
- Author
-
Groenland FTW, Huang J, Scoccia A, Neleman T, Ziedses Des Plantes AC, Nuis RJ, den Dekker WK, Wilschut JM, Diletti R, Kardys I, Van Mieghem NM, and Daemen J
- Subjects
- Humans, Treatment Outcome, Retrospective Studies, Coronary Angiography, ST Elevation Myocardial Infarction diagnostic imaging, ST Elevation Myocardial Infarction surgery, Fractional Flow Reserve, Myocardial physiology, Myocardial Infarction etiology, Percutaneous Coronary Intervention adverse effects, Coronary Artery Disease therapy
- Abstract
Background: Complete revascularization in patients with ST-segment elevation myocardial (STEMI) improves clinical outcome. Vessel fractional flow reserve (vFFR) has been validated as a non-invasive physiological technology to evaluate hemodynamic lesion significance without need for a dedicated pressure wire or hyperemic agent. This study aimed to assess discordance between vFFR reclassification and treatment strategy in intermediate non-culprit lesions of STEMI patients and to assess the clinical impact of this discordance., Methods: This was a single-center, retrospective cohort study. From January 2018 to December 2019, consecutive eligible STEMI patients were screened based on the presence of a non-culprit vessel with an intermediate lesion (30-80% angiographic stenosis) feasible for offline vFFR analysis. The primary outcome was the percentage of non-culprit vessels with discordance between vFFR and actual treatment strategy. The secondary outcome was two-year vessel-oriented composite endpoint (VOCE), a composite of vessel-related cardiovascular death, vessel-related myocardial infarction, and target vessel revascularization., Results: A total of 441 patients (598 non-culprit vessels) met the inclusion criteria. Median vFFR was 0.85 (0.73-0.91). Revascularization was performed in 34.4% of vessels. Discordance between vFFR and actual treatment strategy occurred in 126 (21.1%) vessels. Freedom from VOCE was higher for concordant vessels (97.5%) as compared to discordant vessels (90.6%)(p = 0.003), particularly due to higher adverse event rates in discordant vessels with a vFFR ≤0.80 but deferred revascularization., Conclusions: In STEMI patients with multivessel disease, discordance between vFFR reclassification and treatment strategy was observed in 21.1% of non-culprit vessels with an intermediate lesion and was associated with increased vessel-related adverse events., Competing Interests: Declaration of Competing Interest Nicolas Van Mieghem received institutional research grant support from Abbott Vascular, Abiomed, Boston Scientific, Daiichi-Sankyo, Edward Lifesciences, Medtronic, and PulseCath. Joost Daemen received institutional grant/research support from Abbott Vascular, ACIST Medical, Astra Zeneca, Boston Scientific, Medtronic, Pie Medical, and ReCor Medical. The remaining authors report no relationships that could be construed as a conflict of interest., (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.) more...
- Published
- 2023
- Full Text
- View/download PDF
21. Association Between 3D-Angiography Based Fractional Flow Reserve and Non-Invasive Myocardial Ischemia Testing: The FAST ISCHEMIA Study.
- Author
-
Scoccia A, Neleman T, Tomaniak M, Küçük IT, Masdjedi K, Mahmoud KD, Hirsch A, Kardys I, Van Mieghem NM, Zijlstra F, and Daemen J
- Subjects
- Humans, Cohort Studies, Retrospective Studies, Coronary Angiography methods, Predictive Value of Tests, Ischemia, Fractional Flow Reserve, Myocardial physiology, Coronary Artery Disease diagnosis, Myocardial Ischemia diagnosis, Myocardial Perfusion Imaging methods, Coronary Stenosis
- Abstract
Background: In order to facilitate fractional flow reserve (FFR)-guided lesion assessment, several 3-dimensional (3D)-angiography-based physiological indices have been recently validated. Thus far, limited data are available on the association of these indices with conventional forms of ischemia testing., Aim: The aim of the study was to determine the association between 3D-angiography-based vessel-FFR (vFFR) and myocardial ischemia as assessed by exercise electrocardiography (ECG) testing, dobutamine stress echocardiography, single photon emission computed tomography myocardial perfusion imaging (SPECTMPI), and stress cardiovascular magnetic resonance imaging (stress CMR)., Methods: FAST ISCHEMIA is a retrospective, single-center cohort study including patients who underwent non-invasive myocardial ischemia testing and subsequent coronary angiography (≤3 months). A total of 145 patients (340 vessels) were analyzed. The overall patient-based sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LR+), and negative likelihood ratio (LR-) of vFFR ≤0.80 in any vessel for ischemia was 64% (95% confidence interval [CI], 53-74), 71% (95% CI, 54-84), 83% (95% CI, 72-91), 46% (95% CI, 33-60), 2.16 (95% CI, 1.25-3.74), and 0.52 (95% CI, 0.36-0.74), respectively. Multivariable logistic regression showed that vFFR ≤0.80 was significantly associated with ischemia on a patient level (odds ratio, 8.13; 95% CI, 2.51-30.06; P<.001) and on a vascular territory level (odds ratio, 2.75; 95% CI, 1.17-6.44; P<.01)., Conclusion: Our study suggests that vFFR ≤0.80 has a modest association with non-invasive myocardial ischemia testing using either exercise ECG or stress imaging modalities. After correcting for independent confounders, vFFR was independently associated with ischemia on a non-invasive myocardial ischemia detection test. more...
- Published
- 2023
- Full Text
- View/download PDF
22. Reply: Postintervention Imaging for Optimal Percutaneous Coronary Interventions.
- Author
-
Neleman T, Groenland FTW, and Daemen J
- Subjects
- Humans, Treatment Outcome, Percutaneous Coronary Intervention adverse effects, Percutaneous Coronary Intervention methods, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease therapy
- Published
- 2022
- Full Text
- View/download PDF
23. Reply: Triggering Stent Optimization by Coronary Physiology.
- Author
-
Neleman T and Daemen J
- Subjects
- Humans, Treatment Outcome, Coronary Angiography, Stents, Coronary Restenosis
- Published
- 2022
- Full Text
- View/download PDF
24. Impact of membranous septum length on pacemaker need with different transcatheter aortic valve replacement systems: The INTERSECT registry.
- Author
-
Hokken TW, Muhemin M, Okuno T, Veulemans V, Lopes BB, Beneduce A, Vittorio R, Ooms JF, Adrichem R, Neleman T, Kardys I, Daemen J, Chieffo A, Montorfano M, Cavalcante J, Zeus T, Pilgrim T, Toggweiler S, and Van Mieghem NM more...
- Subjects
- Humans, Male, Aged, 80 and over, Female, Risk Factors, Treatment Outcome, Predictive Value of Tests, Registries, Aortic Valve diagnostic imaging, Aortic Valve surgery, Prosthesis Design, Transcatheter Aortic Valve Replacement adverse effects, Aortic Valve Stenosis diagnostic imaging, Aortic Valve Stenosis surgery, Heart Valve Prosthesis, Pacemaker, Artificial
- Abstract
Background: New permanent pacemaker implantation (new-PPI) remains a compelling issue after Transcatheter Aortic Valve Replacement (TAVR). Previous studies reported the relationship between a short MS length and the new-PPI post-TAVR with a self-expanding THV. However, this relationship has not been investigated in different currently available THV. Therefore, the aim of this study was to investigate the association between membranous septum (MS)-length and new-PPI after TAVR with different Transcatheter Heart Valve (THV)-platforms., Methods: We included patients with a successful TAVR-procedure and an analyzable pre-procedural multi-slice computed tomography. MS-length was measured using a standardized methodology. The primary endpoint was the need for new-PPI within 30 days after TAVR., Results: In total, 1811 patients were enrolled (median age 81.9 years [IQR 77.2-85.4], 54% male). PPI was required in 275 patients (15.2%) and included respectively 14.2%, 20.7% and 6.3% for Sapien3, Evolut and ACURATE-THV(p < 0.01). Median MS-length was significantly shorter in patients with a new-PPI (3.7 mm [IQR 2.2-5.1] vs. 4.1 mm [IQR 2.8-6.0], p = <0.01). Shorter MS-length was a predictor for PPI in patients receiving a Sapien3 (OR 0.87 [95% CI 0.79-0.96], p = <0.01) and an Evolut-THV (OR 0.91 [95% CI 0.84-0.98], p = 0.03), but not for an ACURATE-THV (OR 0.99 [95% CI 0.79-1.21], p = 0.91). By multivariable analysis, first-degree atrioventricular-block (OR 2.01 [95% CI 1.35-3.00], p = <0.01), right bundle branch block (OR 8.33 [95% CI 5.21-13.33], p = <0.01), short MS-length (OR 0.89 [95% CI 0.83-0.97], p < 0.01), annulus area (OR 1.003 [95% CI 1.001-1.005], p = 0.04), NCC implantation depth (OR 1.13 [95% CI 1.07-1.19] and use of Evolut-THV(OR 1.54 [95% CI 1.03-2.27], p = 0.04) were associated with new-PPI., Conclusion: MS length was an independent predictor for PPI across different THV platforms, except for the ACURATE-THV. Based on our study observations within the total cohort, we identified 3 risk groups by MS length: MS length ≤3 mm defined a high-risk group for PPI (>20%), MS length 3-7 mm intermediate risk for PPI (10-20%) and MS length > 7 mm defined a low risk for PPI (<10%). Anatomy-tailored-THV-selection may mitigate the need for new-PPI in patients undergoing TAVR., Competing Interests: Declaration of competing interest Thijmen W. Hokken: none. Mohammed Muhemin: none. Taishi Okuno: none. Verena Veulemans has consulting fees from Medtronic and Edwards lifesciences. Bernardo B. Lopes: none. Alessandro Beneduce: none. Romano Vittorio: none. Joris F. Ooms: none. Rik Adrichem: none. Tara Neleman: none. Isabella Kardys: none. Joost Daemen has received institutional grants from Abbott Vascular, ACIST Medical, Astra Zeneca, Boston Scientific, Medtronic, Microport, Pie Medical and ReCor Medical. A. Chieffo has received speaker/consultant fees from Abbott, Abiomed, Biosensor, Cardinal Health, GADA, and Magenta. Matteo Montorfano has honoraria from Medtronic, Boston Scientific and Abbott. Joao Cavalcante: none. Tobias Zeus has received grants from Medtronic and Edwards lifesciences. Thomas Pilgrim reports research grants to the institution from Edwards Lifesciences, Boston Scientifc and Biotronik, personal fees from Biotronik and Boston Scientific, and other from HighLife SAS. Stefan Toggweiler: has consulting fees from Boston Schientific, Medtronic, Biosensors, Shockwave, Teleflex, Medira, Atheart Medical and VeoSource and stock options from Hi-D imaging. Nicolas M. Van Mieghem received research grants and advisory fees from Abbott, Boston Scientific Corporation, Edwards Lifesciences, Medtronic, Teleflex, Daiichi Sankyo; and from Ancora Heart., (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.) more...
- Published
- 2022
- Full Text
- View/download PDF
25. Reproducibility of 3D Vessel Fractional Flow Reserve (vFFR): A Core Laboratory Variability Analysis of FAST II Study.
- Author
-
Scoccia A, Neleman T, Kardys I, Tanaka N, Van Belle E, Linke A, Bartorelli AL, Ali ZA, Spitzer E, and Daemen J
- Subjects
- Humans, Reproducibility of Results, Coronary Angiography, Fractional Flow Reserve, Myocardial, Coronary Stenosis diagnostic imaging
- Published
- 2022
- Full Text
- View/download PDF
26. Procedural Performance of Ultrathin, Biodegradable Polymer-Coated Stents Versus Durable Polymer-Coated Stents Based on Intracoronary Imaging.
- Author
-
Ziedses des Plantes AC, Neleman T, Tovar Forero MN, Visser L, Scoccia A, Groenland FTW, Ligthart JMR, Boersma E, Nuis RJ, den Dekker WK, Wilschut J, Diletti R, Zijlstra F, Van Mieghem NM, and Daemen J more...
- Subjects
- Humans, Male, Aged, Female, Everolimus, Absorbable Implants, Polymers, Prosthesis Design, Treatment Outcome, Drug-Eluting Stents, Percutaneous Coronary Intervention, Cardiovascular Agents, Coronary Artery Disease therapy
- Abstract
Objective: Thinner stent struts might lead to a higher risk of recoil and subsequently a smaller minimal stent area (MSA), which is known to be the strongest predictor of stent failure. We compared procedural performance between an ultrathin-strut biodegradable-polymer sirolimus-eluting stent (BP-SES) and a durable-polymer zotarolimus-eluting stent (DP-ZES) using intracoronary imaging., Methods: A consecutive cohort of patients underwent percutaneous coronary intervention (PCI) with either BP-SES or DP-ZES in a pseudorandomized fashion between July 2018 and October 2019. In the present subanalysis, we included cases in which post-PCI imaging with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) was performed. The primary endpoint of the study was MSA. Secondary endpoints included percentage stent expansion and presence of residual edge disease, malapposition, tissue protrusion, submedial edge dissections, or edge hematoma., Results: A total of 141 treated lesions (78 BP-SES and 63 DP-ZES) in 127 patients were analyzed. Median age was 69.3 years (interquartile range [IQR], 57.3-75.6) and 74.0% of patients were male. All baseline and procedural characteristics were comparable between both groups. Median MSA was 5.80 mm² (IQR, 4.40-7.24) for BP-SES and 6.35 mm² (IQR, 4.76-8.31) for DP-ZES (P=.15). No significant differences in stent expansion, residual edge disease and presence of malapposition, tissue protrusion, submedial edge dissections, or edge hematomas were found. Stent diameter and stent length were found to be independent predictors of MSA., Conclusions: No significant differences in MSA were found between lesions treated with BP-SES vs DP-ZES. BP-SES and DP-ZES were comparable in terms of procedural performance. more...
- Published
- 2022
- Full Text
- View/download PDF
27. Diagnostic accuracy of angiography-based vessel fractional flow reserve after chronic coronary total occlusion recanalization.
- Author
-
Scoccia A, Scarparo P, Neleman T, Kakar H, Wilschut J, Den Dekker WK, Zijlstra F, Van Mieghem NM, Daemen J, and Diletti R
- Subjects
- Humans, Male, Middle Aged, Aged, Female, Coronary Angiography methods, Predictive Value of Tests, Treatment Outcome, Fractional Flow Reserve, Myocardial physiology, Percutaneous Coronary Intervention adverse effects, Percutaneous Coronary Intervention methods, Coronary Artery Disease diagnosis
- Abstract
Background: Angiography-based vessel fractional flow reserve (vFFR) demonstrated a strong correlation with invasive fractional flow reserve (FFR) in both a pre- and post-percutaneous coronary intervention (PCI) setting. However, the role of vFFR and its correlation with post-PCI FFR in chronic coronary occlusions (CTO) has not been evaluated yet. We sought to investigate the diagnostic performance of post-PCI vFFR with post-PCI FFR as a reference in patients undergoing successful CTO PCI., Methods: Between March 2016 and April 2020, a total of 80 patients from the FFR-SEARCH (prospective registry) and FFR REACT (randomized controlled trial) studies underwent successful CTO recanalization with post-PCI FFR measurements., Results: A total of 50 patients (median age 66 (interquartile range [IQR]: 56-74) years, 76% were male) were eligible for the analysis. Median post-PCI FFR was 0.89 (IQR: 0.84-0.94), while median post-PCI vFFR was 0.91 (IQR: 0.85-0.94) (p 0.10). Suboptimal physiological results, defined as FFR and vFFR <0.90, were identified in 26 (52%) and in 21 (42%) patients, respectively. A strong correlation (r = 0.82) was found between vFFR and FFR with a mean bias of 0.013 ± 0.051. Receiver-operating characteristics curve analysis revealed an excellent accuracy of vFFR in predicting FFR <0.90 (area under the curve: 0.97; 95% confidence interval: 0.93-1.00)., Conclusion: Post-PCI vFFR shows a good correlation with post-PCI FFR and a high diagnostic accuracy for post-PCI FFR ≤0.90 in patients undergoing successful PCI of a CTO lesion., (© 2022 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC.) more...
- Published
- 2022
- Full Text
- View/download PDF
28. Validation of a simplified intravascular ultrasound core lab analysis method in stented coronary arteries.
- Author
-
Neleman T, Khachabi J, Jonker H, Rademaker-Havinga T, Spitzer E, and Daemen J
- Subjects
- Coronary Angiography, Humans, Treatment Outcome, Ultrasonography, Interventional methods, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease therapy, Coronary Vessels diagnostic imaging
- Abstract
Objectives: To validate a simplified core laboratory intravascular ultrasound (IVUS) analysis method based on frames with visually determined minimal lumen areas (MLAs) as compared with a comprehensive (per frame) analysis method., Background: IVUS-guided percutaneous coronary intervention has proven to be superior to angiography-guided stenting. In clinical practice, cross-sections with visually determined MLA are measured to determine lesion severity or minimal stent area (MSA), however, its accuracy has not been compared with a comprehensive per frame analysis method., Methods: A total of 50 stented coronary segments of anonymized core lab datasets were analyzed using a comprehensive analysis method and reanalyzed by two core lab analysts using the simplified method including a maximum of seven frames to be analyzed (the visually determined MSA, the first and last frame, and the MLA of each reference segment). The main parameters of interest were MSA, MLA in the reference segments, and plaque burden., Results: The simplified method showed moderate agreement for measurement of the proximal MLA (7.51 ± 2.52 vs. 6.32 ± 1.88 mm
2 , intraclass correlation coefficient [ICC] = 0.73), good agreement for the distal MLA (5.41 ± 1.85 vs. 5.11 ± 1.38 mm2 , ICC = 0.84) and plaque burden proximal (0.49 ± 0.12 vs. 0.50 ± 0.11, ICC = 0.88), and excellent agreement for the MSA (5.35 ± 1.05 vs. 5.32 ± 0.99 mm2 , ICC = 0.94) and plaque burden distal (0.47 ± 0.14 vs. 0.47 ± 0.12, ICC = 0.92), when compared with the comprehensive analysis method. Inter- and intraobserver analysis revealed good-to-excellent agreement for all parameters., Conclusions: Measuring poststenting IVUS cross-sections with visually determined MLAs by experienced core lab analysts is an accurate and reproducible method to identify MLAs., (© 2022 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC.) more...- Published
- 2022
- Full Text
- View/download PDF
29. Prognostic Implications of Fractional Flow Reserve After Coronary Stenting: A Systematic Review and Meta-analysis.
- Author
-
Hwang D, Koo BK, Zhang J, Park J, Yang S, Kim M, Yun JP, Lee JM, Nam CW, Shin ES, Doh JH, Chen SL, Kakuta T, Toth GG, Piroth Z, Johnson NP, Pijls NHJ, Hakeem A, Uretsky BF, Hokama Y, Tanaka N, Lim HS, Ito T, Matsuo A, Azzalini L, Leesar MA, Neleman T, van Mieghem NM, Diletti R, Daemen J, Collison D, Collet C, and De Bruyne B more...
- Subjects
- Coronary Angiography, Death, Female, Humans, Male, Middle Aged, Prognosis, Treatment Outcome, Drug-Eluting Stents adverse effects, Fractional Flow Reserve, Myocardial physiology, Myocardial Infarction etiology, Percutaneous Coronary Intervention adverse effects
- Abstract
Importance: Fractional flow reserve (FFR) after percutaneous coronary intervention (PCI) is generally considered to reflect residual disease. Yet the clinical relevance of post-PCI FFR after drug-eluting stent (DES) implantation remains unclear., Objective: To evaluate the clinical relevance of post-PCI FFR measurement after DES implantation., Data Sources: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched for relevant published articles from inception to June 18, 2022., Study Selection: Published articles that reported post-PCI FFR after DES implantation and its association with clinical outcomes were included., Data Extraction and Synthesis: Patient-level data were collected from the corresponding authors of 17 cohorts using a standardized spreadsheet. Meta-estimates for primary and secondary outcomes were analyzed per patient and using mixed-effects Cox proportional hazard regression with registry identifiers included as a random effect. All processes followed the Preferred Reporting Items for Systematic Review and Meta-analysis of Individual Participant Data., Main Outcomes and Measures: The primary outcome was target vessel failure (TVF) at 2 years, a composite of cardiac death, target vessel myocardial infarction (TVMI), and target vessel revascularization (TVR). The secondary outcome was a composite of cardiac death or TVMI at 2 years., Results: Of 2268 articles identified, 29 studies met selection criteria. Of these, 28 articles from 17 cohorts provided data, including a total of 5277 patients with 5869 vessels who underwent FFR measurement after DES implantation. Mean (SD) age was 64.4 (10.1) years and 4141 patients (78.5%) were men. Median (IQR) post-PCI FFR was 0.89 (0.84-0.94) and 690 vessels (11.8%) had a post-PCI FFR of 0.80 or below. The cumulative incidence of TVF was 340 patients (7.2%), with cardiac death or TVMI occurring in 111 patients (2.4%) at 2 years. Lower post-PCI FFR significantly increased the risk of TVF (adjusted hazard ratio [HR] per 0.01 FFR decrease, 1.04; 95% CI, 1.02-1.05; P < .001). The risk of cardiac death or MI also increased inversely with post-PCI FFR (adjusted HR, 1.03; 95% CI, 1.00-1.07, P = .049). These associations were consistent regardless of age, sex, the presence of hypertension or diabetes, and clinical diagnosis., Conclusions and Relevance: Reduced FFR after DES implantation was common and associated with the risks of TVF and of cardiac death or TVMI. These results indicate the prognostic value of post-PCI physiologic assessment after DES implantation. more...
- Published
- 2022
- Full Text
- View/download PDF
30. Correlation of 3D Quantitative Coronary-Angiography Based Vessel FFR With Diastolic Pressure Ratio: A Single-Center Pooled Analysis of the FAST EXTEND and FAST II Studies.
- Author
-
Scoccia A, Tomaniak M, Neleman T, Masdjedi K, Groenland FTW, Kardys I, Ligthart JMR, Van Mieghem NM, Spitzer E, and Daemen J
- Subjects
- Blood Pressure, Coronary Angiography, Coronary Vessels diagnostic imaging, Diastole, Humans, Predictive Value of Tests, Severity of Illness Index, Coronary Stenosis diagnosis, Fractional Flow Reserve, Myocardial
- Abstract
Background: Vessel fractional flow reserve (vFFR) has a high diagnostic accuracy in assessing functional lesion significance compared with FFR. Nonhyperemic pressure ratios (NHPRs) were noninferior to FFR to guide revascularization of intermediate lesions. Therefore, the diagnostic performance of vFFR compared with NHPR warrants interest., Aim: To evaluate the diagnostic performance of vFFR with a generic diastolic pressure ratio (dPR) as a reference., Methods: The study population was derived from the FAST EXTEND and FAST II studies. Between January 2016 and September 2020, a total of 475 patients were enrolled., Results: Median dPR was 0.92 (interquartile range [IQR], 0.87-0.95), median vFFR was 0.86 (IQR, 0.80-0.90). The sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy of vFFR ≤0.80 for dPR ≤0.89 were 66%, 92%, 79%, 85%, and 84%, respectively. Vessel FFR showed a good agreement with dPR (r=0.68), consistent among specific clinical lesion subsets and a high diagnostic accuracy for dPR ≤0.89 (area under the curve=0.89). Discordance between vFFR and dPR was observed in 78/492 cases (15.6%) and logistic regression analysis did not reveal any clinical, angiographic, or hemodynamic variables associated with vFFR and dPR discordance., Conclusion: Vessel FFR shows a good agreement with dPR and a high diagnostic accuracy for dPR ≤0.89. more...
- Published
- 2022
- Full Text
- View/download PDF
31. FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: The FFR REACT Trial.
- Author
-
Neleman T, van Zandvoort LJC, Tovar Forero MN, Masdjedi K, Ligthart JMR, Witberg KT, Groenland FTW, Cummins P, Lenzen MJ, Boersma E, Nuis RJ, den Dekker WK, Diletti R, Wilschut J, Zijlstra F, Van Mieghem NM, and Daemen J more...
- Subjects
- Coronary Angiography methods, Humans, Standard of Care, Treatment Outcome, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease therapy, Fractional Flow Reserve, Myocardial, Percutaneous Coronary Intervention adverse effects, Percutaneous Coronary Intervention methods
- Abstract
Background: Post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) <0.90 is common and has been related to impaired patient outcome., Objectives: The authors sought to evaluate if PCI optimization directed by intravascular ultrasound (IVUS) in patients with post-PCI FFR <0.90 could improve 1-year target vessel failure (TVF) rates., Methods: In this single-center, randomized, double-blind trial, patients with a post-PCI FFR <0.90 at the time of angiographically successful PCI were randomized to IVUS-guided optimization or the standard of care (control arm). The primary endpoint was TVF (a composite of cardiac death, spontaneous target vessel myocardial infarction, and clinically driven target vessel revascularization) at 1 year., Results: A total of 291 patients with post-PCI FFR <0.90 were randomized (IVUS-guided optimization arm: n = 145/152 vessels, control arm: n = 146/157 vessels). The mean post-PCI FFR was 0.84 ± 0.05. A total of 104 (68.4%) vessels in the IVUS-guided optimization arm underwent additional optimization including additional stenting (34.9%) or postdilatation only (33.6%), resulting in a mean increase in post-PCI FFR in these vessels from 0.82 ± 0.06 to 0.85 ± 0.05 (P < 0.001) and a post-PCI FFR ≥0.90 in 20% of the vessels. The 1-year TVF rate was comparable between the 2 study arms (IVUS-guided optimization arm: 4.2%, control arm: 4.8%; P = 0.79). There was a trend toward a lower incidence of clinically driven target vessel revascularization in the IVUS-guided optimization arm (0.7% vs. 4.2%, P = 0.06)., Conclusions: IVUS-guided post-PCI FFR optimization significantly improved post-PCI FFR. Because of lower-than-expected event rates, post-PCI FFR optimization did not significantly lower TVF at the 1-year follow-up., Competing Interests: Funding Support and Author Disclosures The Erasmus Medical Center received institutional research support from ACIST Medical Systems, Inc. Dr Diletti has received institutional research grant support from ACIST Medical Systems, Inc. Dr Van Mieghem has received institutional research grant support from Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Daiichi-Sankyo, PulseCath BV, and Abiomed. Dr Daemen has received institutional grant/research support from AstraZeneca, Abbott Vascular, Boston Scientific, ACIST Medical Systems, Inc, Medtronic, Pie Medical, and ReCor medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.) more...
- Published
- 2022
- Full Text
- View/download PDF
32. The prognostic value of angiography-based vessel fractional flow reserve after percutaneous coronary intervention: The FAST Outcome study.
- Author
-
Neleman T, Scoccia A, Masdjedi K, Tomaniak M, Ligthart JMR, Witberg KT, Vermaire A, Wolff Q, Visser L, Cummins P, Kardys I, Wilschut J, Diletti R, Den Dekker WK, Zijlstra F, Van Mieghem NM, and Daemen J more...
- Subjects
- Aged, Coronary Angiography methods, Coronary Vessels diagnostic imaging, Coronary Vessels surgery, Humans, Outcome Assessment, Health Care, Predictive Value of Tests, Prognosis, Treatment Outcome, Coronary Artery Disease, Fractional Flow Reserve, Myocardial, Percutaneous Coronary Intervention adverse effects
- Abstract
Background: Vessel Fractional Flow Reserve (vFFR) as assessed by three-dimensional quantitative coronary angiography has high correlation with pressure wire-based fractional flow reserve in both a pre- and post-PCI setting. The present study aims to assess the prognostic value of post-PCI vFFR on the incidence of target vessel failure (TVF), a composite endpoint of cardiac death, target vessel myocardial infarction and target vessel revascularization (TVR) at 5-year follow up., Methods: Post-PCI vFFR was calculated after routine PCI in a total of 748 patients (832 vessels) with available orthogonal angiographic projections of the stented segment., Results: Median age was 65 (IQR 55-74) years, 18.2% were diabetic, and 29.1% presented with stable angina. Median post-PCI vFFR was 0.91 (IQR 0.86-0.95). Vessels were categorized into tertiles based on post-PCI vFFR: low (vFFR <0.88), middle (vFFR 0.88-0.93), and upper (vFFR ≥0.94). Vessels in the lower and middle tertile were more often LADs and had smaller stent diameters (p<0.001). Vessels in the lower and middle tertile had a higher risk of TVF as compared to vessels in the upper tertile (24.6% and 21.5% vs. 17.1%; adjusted HR 1.84 (95%CI 1.15-2.95), p = 0.011, and 1.58 (95%CI 1.02-2.45), p = 0.040) at 5-years follow-up. Additionally, vessels in the lower tertile had higher rates of TVR as compared to vessels in the higher tertile (12.6% vs. 6.5%, adjusted HR 1.93 (95%CI 1.06-3.53), p = 0.033)., Conclusion: Lower post-PCI vFFR values are associated with a significantly increased risk of TVF and TVR at 5-years follow-up., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.) more...
- Published
- 2022
- Full Text
- View/download PDF
33. Angiography-Based Fractional Flow Reserve: State of the Art.
- Author
-
Scoccia A, Tomaniak M, Neleman T, Groenland FTW, Plantes ACZD, and Daemen J
- Subjects
- Coronary Angiography methods, Coronary Vessels diagnostic imaging, Humans, Predictive Value of Tests, Prospective Studies, Severity of Illness Index, Coronary Artery Disease, Coronary Stenosis diagnostic imaging, Fractional Flow Reserve, Myocardial physiology, Percutaneous Coronary Intervention
- Abstract
Purpose of Review: Three-dimensional quantitative coronary angiography-based methods of fractional flow reserve (FFR) derivation have emerged as an appealing alternative to conventional pressure-wire-based physiological lesion assessment and have the potential to further extend the use of physiology in general. Here, we summarize the current evidence related to angiography-based FFR and perspectives on future developments., Recent Findings: Growing evidence suggests good diagnostic performance of angiography-based FFR measurements, both in chronic and acute coronary syndromes, as well as in specific lesion subsets, such as long and calcified lesions, left main coronary stenosis, and bifurcations. More recently, promising results on the superiority of angiography-based FFR as compared to angiography-guided PCI have been published. Currently available angiography -FFR indices proved to be an excellent alternative to invasive pressure wire-based FFR. Dedicated prospective outcome data comparing these indices to routine guideline recommended PCI including the use of FFR are eagerly awaited., (© 2022. The Author(s).) more...
- Published
- 2022
- Full Text
- View/download PDF
34. Intravascular ultrasound-guided versus coronary angiography-guided percutaneous coronary intervention in patients with acute myocardial infarction: A systematic review and meta-analysis.
- Author
-
Groenland FTW, Neleman T, Kakar H, Scoccia A, Ziedses des Plantes AC, Clephas PRD, Chatterjee S, Zhu M, den Dekker WK, Diletti R, Zijlstra F, Mahmoud KD, Van Mieghem NM, and Daemen J
- Subjects
- Coronary Angiography methods, Humans, Treatment Outcome, Ultrasonography, Interventional methods, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease etiology, Coronary Artery Disease surgery, Myocardial Infarction diagnostic imaging, Myocardial Infarction etiology, Myocardial Infarction surgery, Percutaneous Coronary Intervention methods
- Abstract
Background: Intravascular ultrasound (IVUS) can overcome the intrinsic limitations of coronary angiography for lesion assessment and stenting. IVUS improves outcomes of patients presenting with stable or complex coronary artery disease, but dedicated data on the impact of IVUS-guided percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI) remains scarce., Methods: We systematically searched Embase, MEDLINE, Web of Science Core Collection, Cochrane Central Register of Controlled Trials and Google Scholar for studies that compared clinical outcomes for IVUS- versus angio-guided PCI in patients with AMI. The primary endpoint was all-cause mortality and the secondary endpoint major adverse cardiovascular events (MACE). Mantel-Haenszel random-effects model was used to calculate pooled risk ratios (RR) with 95% confidence intervals (CI)., Results: Nine studies (8 observational, 1 RCT) with a total of 838.902 patients (796.953 angio-guided PCI, 41.949 IVUS-guided PCI) were included. In patients with AMI, IVUS-guided PCI was associated with a significantly lower risk of all-cause mortality (pooled RR: 0.70; 95% CI, 0.59-0.82; p < 0.01), MACE (pooled RR: 0.86; 95% CI, 0.74-0.99; p = 0.04) and target vessel revascularization (TVR) (pooled RR: 0.83; 95% CI, 0.73-0.95; p < 0.01). In the subset of patients presenting with ST-segment elevation, IVUS-guided PCI remained associated with a reduced risk for both all-cause mortality (pooled RR: 0.79; 95% CI, 0.66-0.95, p = 0.01) and MACE (pooled RR: 0.86; 95% CI, 0.74-0.99, p = 0.04)., Conclusions: This is the first systematic review and meta-analysis comparing IVUS- versus angio-guided PCI in patients with AMI, showing a beneficial effect of IVUS-guided PCI on all-cause mortality, MACE and TVR. Results of ongoing dedicated prospective studies are needed to confirm these findings., (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.) more...
- Published
- 2022
- Full Text
- View/download PDF
35. Three-dimensional QCA-based vessel fractional flow reserve (vFFR) in Heart Team decision-making: a multicentre, retrospective, cohort study.
- Author
-
Tomaniak M, Masdjedi K, Neleman T, Kucuk IT, Vermaire A, van Zandvoort LJC, Van Boven N, van Dalen BM, Soei LK, den Dekker WK, Kardys I, Wilschut JM, Diletti R, Zijlstra F, Van Mieghem NM, and Daemen J more...
- Subjects
- Cohort Studies, Coronary Angiography methods, Coronary Vessels diagnostic imaging, Female, Humans, Male, Retrospective Studies, Fractional Flow Reserve, Myocardial
- Abstract
Objectives: To evaluate the feasibility of three-vessel three-dimensional (3D) quantitative coronary angiography (QCA)-based fractional flow reserve (FFR) computation in patients discussed within the Heart Team in whom the treatment decision was based on angiography alone, and to evaluate the concordance between 3D QCA-based vessel FFR (vFFR)-confirmed functional lesion significance and revascularisation strategy as proposed by the Heart Team., Design: Retrospective, cohort., Setting: 3D QCA-based FFR indices have not yet been evaluated in the context of Heart Team decision-making; consecutive patients from six institutions were screened for eligibility and three-vessel vFFR was computed by blinded analysts., Participants: Consecutive patients with chronic coronary syndrome or unstable angina referred for Heart Team consultation. Exclusion criteria involved: presentation with acute myocardial infarction (MI), significant valve disease, left ventricle ejection fraction <30%, inadequate quality of angiogram precluding vFFR computation in all three epicardial coronary arteries (ie, absence of a minimum of two angiographic projections with views of at least 30° apart, substantial foreshortening/overlap of the vessel, poor contrast medium injection, ostial lesions, chronic total occlusions)., Primary and Secondary Outcome Measures: Discordance between vFFR-confirmed lesion significance and revascularisation was assessed as the primary outcome measure. Rates of major adverse cardiac events (MACE) defined as cardiac death, MI and clinically driven revascularisation were reported., Results: Of a total of 1003 patients were screened for eligibility, 416 patients (age 65.6±10.6, 71.2% male, 53% stable angina) were included. The most important reason for screening failure was insufficient quality of the angiogram (43%). Discordance between vFFR confirmed lesion significance and revascularisation was found in 124/416 patients (29.8%) corresponding to 149 vessels (46/149 vessels (30.9%) were reclassified as significant and 103/149 vessels (69.1%) as non-significant by vFFR). Over a median of 962 days, the cumulative incidence of MACE was 29.7% versus 18.5% in discordant versus concordant patients (p=0.031)., Conclusions: vFFR computation is feasible in around 40% of the patients referred for Heart Team discussion, a limitation that is mostly based on insufficient quality of the angiogram. Three vessel vFFR screening indicated discordance between vFFR confirmed lesion significance and revascularisation in 29.8% of the patients., Competing Interests: Competing interests: MT acknowledges funding as the laureate of the European Society of Cardiology Research and Training Program in the form of the ESC 2018 Grant. KM received institutional grant support from Acist Medical. LJCvZ received institutional research grant support from Acist Medical. NMVM received research grant support from Edwards, Medtronic, Abbott, Boston Scientific, Pulse Cath, Acist Medical and Essential Medical. JD received institutional grant/research support from Abbott Vascular, Boston Scientific, Acist Medical, Medtronic and PulseCath, and consultancy and speaker fees from Acist medical, Boston Scientific, ReCor Medical, Medtronic and Pulse Cath. The remaining authors have nothing to disclose., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.) more...
- Published
- 2022
- Full Text
- View/download PDF
36. Tissue characterisation and primary percutaneous coronary intervention guidance using intravascular ultrasound: rationale and design of the SPECTRUM study.
- Author
-
Groenland FTW, Mahmoud KD, Neleman T, Ziedses des Plantes AC, Scoccia A, Ligthart J, Witberg KT, Nuis RJ, den Dekker WK, Wilschut JM, Diletti R, Zijlstra F, Kardys I, Cummins P, Van Mieghem NM, and Daemen J more...
- Subjects
- Humans, Prospective Studies, Ultrasonography, Interventional, Myocardial Infarction, Percutaneous Coronary Intervention adverse effects, Percutaneous Coronary Intervention methods, Plaque, Atherosclerotic
- Abstract
Introduction: Intravascular ultrasound (IVUS) improves clinical outcome in patients undergoing percutaneous coronary intervention (PCI) but dedicated prospective studies assessing the safety and efficacy of IVUS guidance during primary PCI are lacking., Methods and Analysis: The SPECTRUM study is a prospective investigator-initiated single-centre single-arm observational cohort study aiming to enrol 200 patients presenting with ST-segment elevation myocardial infarct undergoing IVUS-guided primary PCI. IVUS will be performed at baseline, postintervention and postoptimisation (if applicable), using a 40-60 MHz high-definition (HD) system. Baseline tissue characterisation includes the morphological description of culprit lesion plaque characteristics and thrombus as assessed with HD-IVUS. The primary endpoint is target vessel failure at 12 months (defined as a composite of cardiac death, target vessel myocardial infarction and clinically driven target vessel revascularisation). The secondary outcome of interest is IVUS-guided optimisation, defined as IVUS-guided additional balloon dilatation or stent placement. Other endpoints include clinical and procedural outcomes along with post-PCI IVUS findings., Ethics and Dissemination: The protocol of this study was approved by the Ethics Committee of the Erasmus University Medical Center, Rotterdam, the Netherlands. Written informed consent is obtained from all patients. Study findings will be submitted to international peer-reviewed journals in the field of cardiovascular imaging and interventions and will be presented at international scientific meetings., Trial Registration Number: NCT05007535., Competing Interests: Competing interests: JD received institutional grant/research support from Abbott Vascular, ACIST Medical, Astra Zeneca, Boston Scientific, Medtronic, Microport, Pie Medical and ReCor Medical. Nicolas Van Mieghem received institutional research grant support from Abbott Vascular, Abiomed, Boston Scientific, Daiichi-Sankyo, Edward Lifesciences, Medtronic, and PulseCath. Roberto Diletti is consultant to ACIST Medical. JL received speaking fees from Boston Scientific, Philips Volcano, ACIST Medical, Abbott Vascular and Pie Medical., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.) more...
- Published
- 2022
- Full Text
- View/download PDF
37. Comparison of diagnostic accuracy measures of novel 3D quantitative coronary angiography based software and diastolic pressure ratio for fractional flow Reserve. A single center pooled analysis of FAST EXTEND and FAST II studies.
- Author
-
Scoccia A, Neleman T, Tomaniak M, Masdjedi K, Groenland FTW, Kardys I, M R Ligthart J, Van Mieghem NM, Spitzer E, and Daemen J
- Abstract
Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Published
- 2022
- Full Text
- View/download PDF
38. Diagnostic Accuracy of Coronary Angiography-Based Vessel Fractional Flow Reserve (vFFR) Virtual Stenting.
- Author
-
Tomaniak M, Neleman T, Ziedses des Plantes A, Masdjedi K, van Zandvoort LJC, Kochman J, den Dekker WK, Wilschut JM, Diletti R, Kardys I, Zijlstra F, Van Mieghem NM, and Daemen J
- Abstract
3D coronary angiography-based vessel fractional flow reserve (vFFR) proved to be an accurate diagnostic alternative to invasively measured pressure wire based fractional flow reserve (FFR). The ability to compute post-PCI vFFR using pre-PCI vFFR virtual stent analysis is unknown. We aimed to assess the feasibility and diagnostic accuracy of pre-PCI vFFR virtual stenting analysis (residual vFFR) with post-PCI FFR as a reference. This is an observational, single-center retrospective cohort study including consecutive patients from the FFR-SEARCH registry. We blindly calculated residual vFFR from pre-PCI angiograms and compared them to invasive pressure-wire based post-PCI FFR. Inclusion criteria involved presentation with either stable or unstable angina or non-ST elevation myocardial infarction (NSTEMI), ≥1 significant stenosis in one of the epicardial coronary arteries (percentage diameter stenosis of >70% by QCA or hemodynamically relevant stenosis with FFR ≤0.80) and pre procedural angiograms eligible for vFFR analysis. Exclusion criteria comprised patients with ST elevation myocardial infarction (STEMI), coronary bypass grafts, cardiogenic shock or severe hemodynamic instability. Eighty-one pre-PCI residual vFFR measurements were compared to post-PCI FFR and post-PCI vFFR measurements. Mean residual vFFR was 0.91 ± 0.06, mean post-PCI FFR 0.91 ± 0.06 and mean post-PCI vFFR was 0.92 ± 0.05. Residual vFFR showed a high linear correlation (r = 0.84) and good agreement (mean difference (95% confidence interval): 0.005 (−0.002−0.012)) with post-PCI FFR, as well as with post-PCI-vFFR (r = 0.77, mean difference −0.007 (−0.015−0.0003)). Residual vFFR showed good accuracy in the identification of lesions with post-PCI FFR < 0.90 (sensitivity 94%, specificity 71%, area under the curve (AUC) 0.93 (95% CI: 0.86−0.99), p < 0.001). Virtual stenting using vFFR provided an accurate estimation of post-PCI FFR and post-PCI vFFR. Further studies are needed to prospectively validate a vFFR-guided PCI strategy. more...
- Published
- 2022
- Full Text
- View/download PDF
39. The Prognostic Value of a Validated and Automated Intravascular Ultrasound-Derived Calcium Score.
- Author
-
Neleman T, Liu S, Tovar Forero MN, Hartman EMJ, Ligthart JMR, Witberg KT, Cummins P, Zijlstra F, Van Mieghem NM, Boersma E, van Soest G, and Daemen J
- Subjects
- Aged, Automation, Coronary Angiography, Coronary Artery Disease mortality, Coronary Artery Disease therapy, Disease Progression, Female, Humans, Image Interpretation, Computer-Assisted, Male, Middle Aged, Myocardial Revascularization, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Vascular Calcification mortality, Vascular Calcification therapy, Coronary Artery Disease diagnostic imaging, Ultrasonography, Interventional, Vascular Calcification diagnostic imaging
- Abstract
Background: Coronary calcification has been linked to cardiovascular events. We developed and validated an algorithm to automatically quantify coronary calcifications on intravascular ultrasound (IVUS). We aimed to assess the prognostic value of an IVUS-calcium score (ICS) on patient-oriented composite endpoint (POCE)., Methods: We included patients that underwent coronary angiography plus pre-procedural IVUS imaging. The ICS was calculated per patient. The primary endpoint was a composite of all-cause mortality, stroke, myocardial infarction, and revascularization (POCE)., Results: In a cohort of 408 patients, median ICS was 85. Both an ICS ≥ 85 and a 100 unit increase in ICS increased the risk of POCE at 6-year follow-up (adjusted hazard ratio (aHR) 1.51, 95%CI 1.05-2.17, p value = 0.026, and aHR 1.21, 95%CI 1.04-1.41, p value = 0.014, respectively)., Conclusions: The ICS, calculated by a validated automated algorithm derived from routine IVUS pullbacks, was strongly associated with the long-term risk of POCE., (© 2021. The Author(s).) more...
- Published
- 2021
- Full Text
- View/download PDF
40. Polarimetric Signatures of Coronary Thrombus in Patients With Acute Coronary Syndrome.
- Author
-
van Zandvoort LJC, Otsuka K, Villiger M, Neleman T, Dijkstra J, Zijlstra F, van Mieghem NM, Bouma BE, and Daemen J
- Subjects
- Coronary Angiography, Coronary Vessels pathology, Humans, Tomography, Optical Coherence methods, Acute Coronary Syndrome diagnostic imaging, Acute Coronary Syndrome pathology, Percutaneous Coronary Intervention methods, Plaque, Atherosclerotic diagnostic imaging, Plaque, Atherosclerotic pathology, Thrombosis diagnostic imaging, Thrombosis pathology
- Abstract
Background: Intravascular polarization-sensitive optical frequency domain imaging (PS-OFDI) offers a novel approach to measure tissue birefringence, which is elevated in collagen and smooth muscle cells, that in turn plays a critical role in healing coronary thrombus (HCT). This study aimed to quantitatively assess polarization properties of coronary fresh and organizing thrombus with PS-OFDI in patients with acute coronary syndrome (ACS)., Methods and results: The POLARIS-I prospective registry enrolled 32 patients with ACS. Pre-procedural PS-OFDI pullbacks using conventional imaging catheters revealed 26 thrombus-regions in 21 patients. Thrombus was manually delineated in conventional OFDI cross-sections separated by 0.5 mm and categorized into fresh thrombus caused by plaque rupture, stent thrombosis, or erosion in 18 thrombus-regions (182 frames) or into HCT for 8 thrombus-regions (141 frames). Birefringence of coronary thrombus was compared between the 2 categories. Birefringence in HCTs was significantly higher than in fresh thrombus (∆n=0.47 (0.37-0.72) vs. ∆n=0.25 (0.17-0.29), P=0.007). In a subgroup analysis, when only using thrombus-regions from culprit lesions, ischemic time was a significant predictor for birefringence (ß (∆n)=0.001 per hour, 95% CI [0.0002-0.002], P=0.023)., Conclusions: Intravascular PS-OFDI offers the opportunity to quantitatively assess the polarimetric properties of fresh and organizing coronary thrombus, providing new insights into vascular healing and plaque stability. more...
- Published
- 2021
- Full Text
- View/download PDF
41. Impact of Poststenting Fractional Flow Reserve on Long-Term Clinical Outcomes: The FFR-SEARCH Study.
- Author
-
Diletti R, Masdjedi K, Daemen J, van Zandvoort LJC, Neleman T, Wilschut J, Den Dekker WK, van Bommel RJ, Lemmert M, Kardys I, Cummins P, de Jaegere P, Zijlstra F, and Van Mieghem NM
- Subjects
- Coronary Angiography, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease therapy, Hemodynamics, Humans, Percutaneous Coronary Intervention adverse effects, Treatment Outcome, Fractional Flow Reserve, Myocardial
- Abstract
[Figure: see text].
- Published
- 2021
- Full Text
- View/download PDF
42. Correlation between 3D-QCA based FFR and quantitative lumen assessment by IVUS for left main coronary artery stenoses.
- Author
-
Tomaniak M, Masdjedi K, van Zandvoort LJ, Neleman T, Tovar Forero MN, Vermaire A, Kochman J, Kardys I, den Dekker W, Wilschut J, Diletti R, de Jaegere P, Van Mieghem NM, Zijlstra F, and Daemen J
- Subjects
- Cohort Studies, Coronary Angiography, Coronary Vessels diagnostic imaging, Humans, Male, Predictive Value of Tests, Severity of Illness Index, Treatment Outcome, Ultrasonography, Interventional, Coronary Stenosis diagnostic imaging, Fractional Flow Reserve, Myocardial
- Abstract
Objectives: We aimed to evaluate the feasibility of using three dimensional-quantitative coronary angiography (3D-QCA) based fractional flow reserve (FFR) (vessel fractional flow reserve [vFFR], CAAS8.1, Pie Medical Imaging) and to correlate vFFR values with intravascular ultrasound (IVUS) for the evaluation of intermediate left main coronary artery (LMCA) stenosis., Background: 3D-QCA derived FFR indices have been recently developed for less invasive functional lesion assessment. However, LMCA lesions were vastly under-represented in first validation studies., Methods: This observational single-center cohort study enrolled consecutive patients with stable angina, unstable angina, or non-ST-segment elevation myocardial infarction and nonostial, intermediate grade LMCA stenoses who underwent IVUS evaluation. vFFR was computed based on two angiograms with optimal LMCA stenosis projection and correlated with IVUS-derived minimal lumen area (MLA)., Results: A total of 256 patients with intermediate grade LMCA stenosis evaluated with IVUS were screened for eligibility; 147 patients met the clinical inclusion criteria and had a complete IVUS LMCA footage available, of them, 63 patients (63 lesions) underwent 3D-QCA and vFFR analyses. The main reason for screening failure was insufficient quality of the angiogram (51 patients,60.7%). Mean age was 65 ± 11 years, 75% were male. Overall, mean MLA within LMCA was 8.77 ± 3.17 mm
2 , while mean vFFR was 0.87 ± 0.09. A correlation was observed between vFFR and LMCA MLA (r = .792, p = .001). The diagnostic accuracy of vFFR ≤0.8 in identifying lesions with MLA < 6.0 mm2 (sensitivity 98%, specificity 71.4%, area under the curve (AUC) 0.95, 95% confidence interval (CI) 0.89-1.00, p = .001) was good., Conclusions: In patients with good quality angiographic visualization of LMCA and available complete LMCA IVUS footage, 3D-QCA based vFFR assessment of LMCA disease correlates well to LMCA MLA as assessed by IVUS., (© 2020 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC.) more...- Published
- 2021
- Full Text
- View/download PDF
43. Extended Validation of Novel 3D Quantitative Coronary Angiography-Based Software to Calculate vFFR: The FAST EXTEND Study.
- Author
-
Neleman T, Masdjedi K, Van Zandvoort LJC, Tomaniak M, Ligthart JMR, Witberg KT, Vermaire AA, Boersma E, Van Mieghem NM, and Daemen J
- Subjects
- Coronary Vessels, Fractional Flow Reserve, Myocardial, Humans, Predictive Value of Tests, Software, Coronary Angiography
- Published
- 2021
- Full Text
- View/download PDF
44. Polarimetric Signatures of Vascular Tissue Response to Drug-Eluting Stent Implantation in Patients.
- Author
-
Otsuka K, Villiger M, van Zandvoort LJC, Neleman T, Karanasos A, Dijkstra J, van Soest G, Regar E, Nadkarni SK, Daemen J, and Bouma BE
- Subjects
- Coronary Vessels, Humans, Neointima, Predictive Value of Tests, Stents, Treatment Outcome, Drug-Eluting Stents
- Published
- 2020
- Full Text
- View/download PDF
45. Impact of intravascular ultrasound findings in patients with a post PCI fractional flow reserve ≤0.85 on 2 year clinical outcome.
- Author
-
van Zandvoort LJC, Masdjedi K, Neleman T, Tovar Forero MN, Wilschut J, den Dekker W, de Jaegere PPT, Diletti R, Zijlstra F, Van Mieghem NM, and Daemen J
- Subjects
- Coronary Angiography, Humans, Treatment Outcome, Ultrasonography, Interventional, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease surgery, Drug-Eluting Stents, Fractional Flow Reserve, Myocardial, Percutaneous Coronary Intervention
- Abstract
Background: Patients with a low post PCI fractional flow reserve (FFR) are at increased risk for future adverse cardiac events. The aim of the present study was to assess the impact of specific intravascular ultrasound (IVUS) findings in patients with a low post percutaneous coronary intervention (PCI) FFR on long-term clinical outcome., Methods: In a subgroup analysis, 100 vessels with an FFR value ≤0.85 underwent post PCI IVUS to further assess the potential determinants for low post PCI FFR. No further action was taken to improve post PCI FFR. The primary endpoint of this study was the event free survival of target vessel failure (TVF) at two years in patients with a post PCI FFR ≤0.85, which was defined as a composite of cardiac death, target vessel myocardial infarction or target vessel revascularization., Results: In patients with a post PCI FFR ≤0.85, TVF free survival rates were 88.5% vs. 95.5% for patients with versus without residual proximal lesions and 88.2% vs. 95.5% for patients with versus without residual distal lesions respectively (HR = 2.53, 95% confidence interval (CI) 0.52-12.25, p = .25 and HR = 2.60, 95% CI 0.54-12.59, p = .24 respectively). TVF free survival was 92.8% vs. 93.5% in patients with versus without stent underexpansion >20% (HR = 1.01, 95% CI 0.21-4.88, p = .99) and 89.3% vs. 97.8% in patients with versus without any residual focal lesion including lumen compromising hematoma (HR = 4.64, 95% CI 0.55-39.22, p = .18)., Conclusion: Numerically higher TVF rates were observed in patients with a post PCI FFR ≤0.85 and clear focal residual disease as assessed with IVUS., Competing Interests: Declaration of Competing Interest LvZ received institutional research support from ACIST medical Inc. TN received institutional research support from ACIST medical Inc. JD reports to have received institutional research support from Pie Medical, ACIST Medical Inc., PulseCath, Medtronic, Boston Scientific, Abbott Vascular and speaker and consultancy fees from PulseCath, Medtronic, ReCor Medical, Acist Medical Inc. All other co-authors have no relevant conflict of interests to declare., (Copyright © 2020. Published by Elsevier B.V.) more...
- Published
- 2020
- Full Text
- View/download PDF
46. Automated Quantitative Assessment of Coronary Calcification Using Intravascular Ultrasound.
- Author
-
Liu S, Neleman T, Hartman EMJ, Ligthart JMR, Witberg KT, van der Steen AFW, Wentzel JJ, Daemen J, and van Soest G
- Subjects
- Automation, Humans, Coronary Artery Disease diagnostic imaging, Plaque, Atherosclerotic diagnostic imaging, Ultrasonography, Interventional, Vascular Calcification diagnostic imaging
- Abstract
Coronary calcification represents a challenge in the treatment of coronary artery disease by stent placement. It negatively affects stent expansion and has been related to future adverse cardiac events. Intravascular ultrasound (IVUS) is known for its high sensitivity in detecting coronary calcification. At present, automated quantification of calcium as detected by IVUS is not available. For this reason, we developed and validated an optimized framework for accurate automated detection and quantification of calcified plaque in coronary atherosclerosis as seen by IVUS. Calcified lesions were detected by training a supported vector classifier per IVUS A-line on manually annotated IVUS images, followed by post-processing using regional information. We applied our framework to 35 IVUS pullbacks from each of the three commonly used IVUS systems. Cross-validation accuracy for each system was >0.9, and the testing accuracy was 0.87, 0.89 and 0.89 for the three systems. Using the detection result, we propose an IVUS calcium score, based on the fraction of calcium-positive A-lines in a pullback segment, to quantify the extent of calcified plaque. The high accuracy of the proposed classifier suggests that it may provide a robust and accurate tool to assess the presence and amount of coronary calcification and, thus, may play a role in image-guided coronary interventions., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.) more...
- Published
- 2020
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.